Cargando…

The Management of Type 2 Diabetic Patients with Hypoglycemic Agents

Aims and Scope. Aims of the paper are to suggest the best treatment to improve the glycemic control in patients with Type 2 diabetes using hypoglycemic agents, in particularly, we think that every patient is different from another one in terms of BMI, family history, duration of the disease and so o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carnevale Schianca, G. P., Sola, D., Rossi, L., Fra, G. P., Bartoli, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scholarly Research Network 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335186/ https://www.ncbi.nlm.nih.gov/pubmed/22577575 http://dx.doi.org/10.5402/2012/601380

Ejemplares similares

Oral glucose tolerance test‐based calculation identifies different glucose intolerance phenotypes within the impaired fasting glucose range
por: Carnevale Schianca, Gian Piero, et al.
Publicado: (2014)

Sulfonylureas and their use in clinical practice
por: Sola, Daniele, et al.
Publicado: (2015)

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents
por: Dawed, Adem Yesuf, et al.
Publicado: (2016)

Combination therapy of oral hypoglycemic agents in patients with type 2 diabetes mellitus
por: Moon, Min Kyong, et al.
Publicado: (2017)

Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus
por: Moon, Min Kyong, et al.
Publicado: (2017)

Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan
por: Bashir, Mir Iftikhar, et al.
Publicado: (2012)

Bioactives of Momordica charantia as Potential Anti-Diabetic/Hypoglycemic Agents
por: Xu, Bilin, et al.
Publicado: (2022)

Evaluation of Adherence to Oral Hypoglycemic Agent Prescription in Patients with Type 2 Diabetes
por: Irani, Mahtab, et al.
Publicado: (2021)

The Impact of Hypoglycemic Therapy on the Prognosis for Acute Coronary Syndrome in Patients with Type 2 Diabetes
por: Nikolaev, K. Yu., et al.
Publicado: (2022)

Adherence to Hypoglycemic Agents in Type 2 Diabetes Mellitus: A Cross-Sectional Study
por: Khayyat, Yara A, et al.
Publicado: (2022)

Opportunities and challenges of incretin-based hypoglycemic agents treating type 2 diabetes mellitus from the perspective of physiological disposition
por: Xie, Yaochen, et al.
Publicado: (2023)

Hypoglycemic agents and potential anti-inflammatory activity
por: Kothari, Vishal, et al.
Publicado: (2016)

The Impact of Bariatric Surgery on Type 2 Diabetes Mellitus and the Management of Hypoglycemic Events
por: Kassem, Mahmoud Attia Mohamed, et al.
Publicado: (2017)

Latent autoimmune diabetes of adults: From oral hypoglycemic agents to early insulin
por: Poudel, Resham R.
Publicado: (2012)

Oral hypoglycemic agents: do the ends justify the means?
por: Langer, Oded
Publicado: (2015)

Utility of Hypoglycemic Agents to Treat Asthma with Comorbid Obesity
por: Ge, Derek, et al.
Publicado: (2022)

Effect of Hypoglycemic Agents on Ischemic Preconditioning in Patients With Type 2 Diabetes and Symptomatic Coronary Artery Disease
por: Rahmi, Rosa Maria, et al.
Publicado: (2013)

Increased Risk of Severe Hypoglycemic Events with Increasing Frequency of Non-severe Hypoglycemic Events in Patients with Type 1 and Type 2 Diabetes
por: Sreenan, Seamus, et al.
Publicado: (2014)

Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?
por: Górriz, Jose Luis, et al.
Publicado: (2015)

Factors Associated with Long-Term Oral Hypoglycemic Agent Responsiveness in Korean Patients with Type 2 Diabetes Mellitus
por: Kim, Bo-Yeon, et al.
Publicado: (2011)

Comparative evaluation of biphasic insulin with metformin and triple oral hypoglycemic agents (OHA) in type 2 diabetes patients
por: Alavudeen, Sirajudeen Shaik, et al.
Publicado: (2020)

Hypoglycemic agents and glycemic variability in individuals with type 2 diabetes: A systematic review and network meta-analysis
por: Oh, SuA, et al.
Publicado: (2022)

Adherence to Oral Hypoglycemic Agents in Hawaii
por: Lee, Rachel, et al.
Publicado: (2005)

Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice
por: Sun, Jing, et al.
Publicado: (2015)

Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents: Basal or prandial insulin? The APOLLO trial and beyond
por: Bretzel, Reinhard G., et al.
Publicado: (2009)

Factors Associated with Glycemic Variability in Patients with Type 2 Diabetes: Focus on Oral Hypoglycemic Agents and Cardiovascular Risk Factors
por: Yoo, Soyeon, et al.
Publicado: (2015)

Effect of high-dose zinc supplementation with oral hypoglycemic agents on glycemic control and inflammation in type-2 diabetic nephropathy patients
por: Khan, Mohd Idreesh, et al.
Publicado: (2013)

Durability of oral hypoglycemic agents in drug naïve patients with type 2 diabetes: report from the Swedish National Diabetes Register (NDR)
por: Ekström, Nils, et al.
Publicado: (2015)

Management of diabetes mellitus in the elderly with canagliflozin: A newer hypoglycemic drug on the horizon
por: Sehgal, Vishal, et al.
Publicado: (2014)

Effect of Cyclocarya Paliurus on Hypoglycemic Effect in Type 2 Diabetic Mice
por: Zhao, Lichun, et al.
Publicado: (2019)

Hypoglycemic mechanism of intestinal bypass surgery in type 2 diabetic rats
por: Xie, Siqi, et al.
Publicado: (2021)

Editorial: Non-insulin hypoglycemic drugs in type 2 diabetes remission
por: Guo, Kai-heng, et al.
Publicado: (2023)

Thiazolidin-2,4-Dione Scaffold: An Insight into Recent Advances as Antimicrobial, Antioxidant, and Hypoglycemic Agents
por: Kumar, Harsh, et al.
Publicado: (2022)

Drug-drug interaction between voriconazole and oral hypoglycemic agents in diabetic rats
por: Kumar, Boyina Hemanth, et al.
Publicado: (2013)

Hypoglycemic agents and incidence of pancreatic cancer in diabetic patients: a meta-analysis
por: Zhao, Zimo, et al.
Publicado: (2023)

New hypoglycemic agents and the kidney: what do the major trials tell us?
por: Smyth, Brendan, et al.
Publicado: (2018)

Characteristics Predictive for a Successful Switch from Insulin Analogue Therapy to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes
por: Kim, Gyuri, et al.
Publicado: (2016)

Association between hypoglycemic agent use and the risk of occurrence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
por: Jung, Choungwon, et al.
Publicado: (2023)

Analysis of Risk Factors for Hypoglycemic Coma in 194 Patients with Type 2 Diabetes
por: Lu, Zefen, et al.
Publicado: (2017)

Adherence to Hypoglycemic Medication among Insulin-Treated Patients with Type 2 Diabetes
por: Zarei-Shargh, Parisa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mkuac4qb3vueutl00h2qvdd3ac